-
公开(公告)号：US20050153924A1
公开(公告)日：2005-07-14
申请号：US11013543
申请日：2004-12-15
申请人： C. Bennett , Brett Monia , Susan Murray , Madeline Butler , Nicholas Dean , Rosanne Crooke , Mark Graham , Hong Zhang , Susan Freier , Brenda Baker , Eric Marcusson , Jacqueline Wyatt , Lex Cowsert , Kenneth Dobie , Andrew Watt
发明人： C. Bennett , Brett Monia , Susan Murray , Madeline Butler , Nicholas Dean , Rosanne Crooke , Mark Graham , Hong Zhang , Susan Freier , Brenda Baker , Eric Marcusson , Jacqueline Wyatt , Lex Cowsert , Kenneth Dobie , Andrew Watt
IPC分类号： A61K38/00 , A61K48/00 , C07H21/02 , C12N15/113 , C12Q1/68
CPC分类号： C12N15/1138 , A61K38/00 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , Y02P20/582 , C12N2310/3525
摘要： Antisense compounds, compositions and methods are provided for modulating the expression of Interferon gamma receptor 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Interferon gamma receptor 2. Methods of using these compounds for modulation of Interferon gamma receptor 2 expression and for treatment of diseases associated with expression of Interferon gamma receptor 2 are provided.
摘要翻译： 提供反义化合物，组合物和方法用于调节干扰素γ受体2的表达。组合物包含靶向编码干扰素γ受体2的核酸的反义化合物，特别是反义寡核苷酸。使用这些化合物调节干扰素γ受体2的方法 提供了与干扰素γ受体2表达相关的疾病的表达和治疗。
-
公开(公告)号：US20050227938A1
公开(公告)日：2005-10-13
申请号：US11015193
申请日：2004-12-17
申请人： C. Bennett , Brenda Baker , Nicholas Dean , Brett Monia , Susan Freier , James Karras , Hong Zhang , Susan Murray , Madeline Butler , Erich Koller , Thomas Condon , William Gaarde , Andrew Watt , Mark Graham , Jacqueline Wyatt , Lex Cowsert , Kenneth Dobie , Mark Roach
发明人： C. Bennett , Brenda Baker , Nicholas Dean , Brett Monia , Susan Freier , James Karras , Hong Zhang , Susan Murray , Madeline Butler , Erich Koller , Thomas Condon , William Gaarde , Andrew Watt , Mark Graham , Jacqueline Wyatt , Lex Cowsert , Kenneth Dobie , Mark Roach
IPC分类号： A61K38/00 , A61K48/00 , C07H21/02 , C12N15/113
CPC分类号： C12N15/1138 , A61K38/00 , C12N2310/315 , C12N2310/321 , C12N2310/322 , C12N2310/335 , C12N2310/341 , C12N2310/346 , Y02P20/582 , C12N2310/3521 , C12N2310/3525
摘要： Antisense compounds, compositions and methods are provided for modulating the expression of TFAP2C. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding TFAP2C. Methods of using these compounds for modulation of TFAP2C expression and for treatment of diseases associated with expression of TFAP2C are provided.
摘要翻译： 提供反义化合物，组合物和方法用于调节TFAP2C的表达。 组合物包含靶向编码TFAP2C的核酸的反义化合物，特别是反义寡核苷酸。 提供了使用这些化合物调节TFAP2C表达和治疗与TFAP2C表达相关的疾病的方法。
-
公开(公告)号：US20060160758A1
公开(公告)日：2006-07-20
申请号：US11039632
申请日：2005-01-20
申请人： C. Bennett , Susan Freier , Brenda Baker , Brett Monia , Nicholas Dean , Hong Zhang , Susan Murray , Lex Cowsert , Madeline Butler , Robert McKay , Donna Ward , William Gaarde , Ian Popoff , Jacqueline Wyatt , Andrew Watt
发明人： C. Bennett , Susan Freier , Brenda Baker , Brett Monia , Nicholas Dean , Hong Zhang , Susan Murray , Lex Cowsert , Madeline Butler , Robert McKay , Donna Ward , William Gaarde , Ian Popoff , Jacqueline Wyatt , Andrew Watt
CPC分类号： C12N15/1138 , C12N2310/11 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , Y02P20/582 , C12N2310/3525
摘要： Antisense compounds, compositions and methods are provided for modulating the expression of CD40 ligand. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding CD40 ligand. Methods of using these compounds for modulation of CD40 ligand expression and for treatment of diseases associated with expression of CD40 ligand are provided.
-
公开(公告)号：US20060074043A1
公开(公告)日：2006-04-06
申请号：US11250884
申请日：2005-10-13
申请人： Brett Monia , Susan Freier , Sanjay Bhanot , Madeline Butler , Andrew Watt , Jacqueline Wyatt , Brenda Baker , Lex Cowsert , Kenneth Dobie
发明人： Brett Monia , Susan Freier , Sanjay Bhanot , Madeline Butler , Andrew Watt , Jacqueline Wyatt , Brenda Baker , Lex Cowsert , Kenneth Dobie
CPC分类号： C12N15/1138 , A61K38/00 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , Y02P20/582 , C12N2310/3525
摘要： Antisense compounds, compositions and methods are provided for modulating the expression of matrix metalloproteinase 1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding matrix metalloproteinase 1. Methods of using these compounds for modulation of matrix metalloproteinase 1 expression and for treatment of diseases associated with expression of matrix metalloproteinase 1 are provided.
-
公开(公告)号：US20050095710A1
公开(公告)日：2005-05-05
申请号：US11008747
申请日：2004-12-09
申请人： Lex Cowsert , Jacqueline Wyatt , Susan Freier , Brett Monia , Madeline Butler , Robert McKay
发明人： Lex Cowsert , Jacqueline Wyatt , Susan Freier , Brett Monia , Madeline Butler , Robert McKay
IPC分类号： C12N15/09 , A61K31/7115 , A61K31/712 , A61K31/7125 , A61K38/00 , A61K48/00 , A61P3/04 , A61P3/10 , A61P35/00 , C12N15/113 , C07H21/02
CPC分类号： C12N15/1137 , A61K38/00 , A61K48/00 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/345 , C12N2310/346 , C12Y301/03048 , Y02P20/582 , C12N2310/3525
摘要： Compounds, compositions and methods are provided for modulating the expression of PTP1B. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding PTP1B. Methods of using these compounds for modulation of PTP1B expression and for treatment of diseases associated with expression of PTP1B are provided.
摘要翻译： 提供化合物，组合物和方法用于调节PTP1B的表达。 组合物包含靶向编码PTP1B的核酸的反义化合物，特别是反义寡核苷酸。 提供了使用这些化合物调节PTP1B表达和治疗与PTP1B表达相关的疾病的方法。
-
公开(公告)号：US20060003953A1
公开(公告)日：2006-01-05
申请号：US11004762
申请日：2004-12-03
申请人： C. Bennett , Madeline Butler , Nicholas Dean , Kenneth Dobie , Joshua Finger , Ravi Jain , Robert McKay , Brett Monia , Kathleen Myers
发明人： C. Bennett , Madeline Butler , Nicholas Dean , Kenneth Dobie , Joshua Finger , Ravi Jain , Robert McKay , Brett Monia , Kathleen Myers
CPC分类号： C07H21/04
摘要： Disclosed herein are compounds, compositions and methods for modulating the expression of a bone growth modulator in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders.
摘要翻译： 本文公开了用于调节细胞，组织或动物中骨生长调节剂的表达的化合物，组合物和方法。 还提供了目标验证的方法。 还提供了所公开的化合物和组合物在制备用于治疗疾病和病症的药物中的用途。
-
公开(公告)号：US20060030045A1
公开(公告)日：2006-02-09
申请号：US10297056
申请日：2001-06-11
申请人： Brett Monia , Madeline Butler , Jacqueline Wyatt
发明人： Brett Monia , Madeline Butler , Jacqueline Wyatt
CPC分类号： C12N15/113 , A61K38/00 , C12N2310/315 , C12N2310/321 , C12N2310/3341 , C12N2310/341 , C12N2310/346 , Y02P20/582 , C12N2310/3525
摘要： Antisense compounds, compositions and methods are provided for modulating the expression of C/EBP beta. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding C/EBP beta. Methods of using these compounds for modulation of C/EBP beta expression and for treatment of diseases associated with expression of C/EBP beta are provided.
摘要翻译： 提供反义化合物，组合物和方法用于调节C /EBPβ的表达。 组合物包含靶向编码C /EBPβ的核酸的反义化合物，特别是反义寡核苷酸。 提供了使用这些化合物调节C /EBPβ表达和治疗与C /EBPβ表达相关的疾病的方法。
-
8.发明申请Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry 审中-公开包括北部和南部构象几何的交替区域的嵌合寡聚化合物公开(公告)号：US20050074801A1
公开(公告)日：2005-04-07
申请号：US10936273
申请日：2004-09-08
申请人： Brett Monia , Madeline Butler , Robert McKay , Brenda Baker
发明人： Brett Monia , Madeline Butler , Robert McKay , Brenda Baker
IPC分类号： C07H21/04 , C12N15/11 , C12N15/113 , C12Q1/68
CPC分类号： C12N15/113 , C07H21/00 , C12N15/111 , C12N2310/32 , C12N2310/321 , C12N2310/323 , C12N2310/3231 , C12N2320/51
摘要： The present invention relates to novel chimeric oligomeric compounds having a plurality of alternating regions having either RNA like having northern or 3′-endo conformational geometry (3′-endo regions) or DNA like having southern or C2′-endo/O4′-endo conformational geometry. The oligomeric compounds of the present invention have shown reduction in mRNA levels in multiple in vitro and in vivo assay systems and are useful, for example, for investigative and therapeutic purposes.
摘要翻译： 本发明涉及具有多个交替区域的新型嵌合寡聚化合物，所述交替区域具有如具有北或3'-端构象几何（3'-末端区域）的RNA或具有南部或C2'端/ O4'端 构象几何。 本发明的寡聚化合物已显示多个体外和体内测定系统中mRNA水平的降低，并且例如用于调查和治疗目的是有用的。
-
-
-
-
-
-
-
搜索结果
8 条记录 (耗时 0.066 秒)
